{1 (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 1... — RxCUI 1250983
RxNorm drug concept · Generic pack
RxCUI 1250983
Generic pack · GPCK
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1250983
Official name{1 (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) / 1 (dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known as1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG Oral Tablet) Pack
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
- Why am I getting acetaminophen through an IV instead of just taking a pill?
- Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
- The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
🕸️ Concept Web — How {1 (acetaminophen 500 MG / chlorpheniramine male... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{1 (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) / 1 (dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule) } Pack
RxCUI 1250983 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 8
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Chlorpheniramine
2400IN -
Dextromethorphan
3289IN -
Guaifenesin
5032IN -
Acetaminophen / chlorpheniramine / dextromethorphan
1007587MIN -
Dextromethorphan / guaifenesin
214488MIN -
Chlorpheniramine maleate
142429PIN -
Dextromethorphan hydrobromide
102490PIN
-
Acetaminophen
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / chlorpheniramine / dextromethorphan Oral Tablet
379159SCDF -
Dextromethorphan / guaifenesin Oral Capsule
371763SCDF -
Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Tablet
2645354SCDFP -
Dextromethorphan hydrobromide / guaifenesin Oral Capsule
2646185SCDFP -
Acetaminophen / chlorpheniramine / dextromethorphan Oral Product
1155233SCDG -
Acetaminophen / chlorpheniramine / dextromethorphan Pill
1155234SCDG -
Dextromethorphan / guaifenesin Oral Product
1155191SCDG -
Dextromethorphan / guaifenesin Pill
1155193SCDG - +7 more in this family
-
Acetaminophen / chlorpheniramine / dextromethorphan Oral Tablet
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet
1098496SCD -
Dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule
1111663SCD -
Acetaminophen 500 MG
315266SCDC -
Chlorpheniramine maleate 2 MG
999433SCDC -
Dextromethorphan hydrobromide 10 MG
1014455SCDC -
Dextromethorphan hydrobromide 15 MG
1089821SCDC -
Guaifenesin 200 MG
317384SCDC
-
Acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet
Showing up to 8 concepts per family — 23 of 30 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet
SCD · 1098496 -
Dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule
SCD · 1111663 -
Acetaminophen 500 MG
SCDC · 315266 -
Chlorpheniramine maleate 2 MG
SCDC · 999433 -
Dextromethorphan hydrobromide 10 MG
SCDC · 1014455 -
Dextromethorphan hydrobromide 15 MG
SCDC · 1089821 -
Guaifenesin 200 MG
SCDC · 317384 -
Acetaminophen / chlorpheniramine / dextromethorphan Oral Tablet
SCDF · 379159 -
Dextromethorphan / guaifenesin Oral Capsule
SCDF · 371763 -
Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Tablet
SCDFP · 2645354
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1250983 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 11523-4765-01 | 1 KIT in 1 CARTON (11523-4765-1) * 2 BLISTER PACK in 1 CAR... | Coricidin HBP Day and Night | Bayer HealthCare LLC. | 2009-08-28 |
Observed labelers:
Bayer HealthCare LLC. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.